Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Lee’s Pharm Finds US Distribution Partner for Short-Acting Anesthetic

publication date: Nov 26, 2013
Lee's Pharmaceutical Holdings, a China drugmaker, has found a partner to market its topical short-term anesthesia product in the US. Marathon Pharmaceuticals signed a 10-year exclusive US licensing agreement for Zingo® (lidocaine hydrochloride monohydrate) powder intradermal injection system. Zingo, with an onset of action of just one to three minutes, is used to allay the pain of a needlestick procedure. Usually, Lee’s is in the news for in-licensing products from the west; Zingo is its first product to be taken back to the US. More details....

Stock Symbol: (HK: 950)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital